Research and Markets: Calcium Signaling Pathway in Cancer Drug Pipeline Update 2014

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/2tsknl/calcium_signaling) has announced the addition of the "Calcium Signaling Pathway in Cancer Drug Pipeline Update 2014" report to their offering.

There are today 159 companies plus partners developing 203 calcium signaling pathway targeting drugs in 799 developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last years amount to another 101 drugs.

Calcium Signaling Pathway In Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 119 different targets. All included targets have been cross-referenced for the presence of mutations associated with human cancer. To date 118 out of the 119 studied drug targets so far have been recorded with somatic mutations.

The software application lets you narrow in on these mutations and links out to the mutational analysis for each of the drug targets for detailed information. All drugs targets are further categorized on in the software application by 28 classifications of molecular function and with pathway referrals to BioCarta, KEGG, NCI-Nature and NetPath.

Drug Pipeline Update at a Glance

Investigators

Includes more than 159 principal companies plus their collaborators. There is direct access from inside the application to web pages of all principal companies.

Drug name & Synonyms

Lists commercial, generic and code names for drugs.

Developmental stage

This Drug Pipeline Update contains 203 calcium signaling pathway targeting drugs in development, which have a total of 799 developmental projects in cancer. In addition there are suspended and ceased drugs.

Indications

Included calcium signaling pathway targeting drugs are also in development for 149 other indications, where of 91 are different cancer indications.

Pipeline Breakdown According to Number of Drugs

  • Marketed # 25
  • Pre-registration # 5
  • Phase III # 38
  • Phase II # 83
  • Phase I # 90
  • Preclinical # 91
  • No Data # 1
  • Suspended # 1
  • Ceased # 101

For more information visit http://www.researchandmarkets.com/research/2tsknl/calcium_signaling

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology